Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR known ✓ | P04035 | 1/20 | 0.42 |
| ▸ | ADORA3 known ✓ | P0DMS8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | DUSP5 | Q16690 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29906996 | 1.00 | LMNA (0.56) | LMNAMAPTALDH1A1KMT2AHTT | |
| SCHEMBL6561127 | 0.90 | ALDH1A1 (0.51) | LMNAMAPTALDH1A1KMT2AHTT | |
| Sulisobenzone SCHEMBL28588923 | 0.89 | LMNA (0.74) | LMNAMAPTALDH1A1KMT2AHTT | |
| SCHEMBL1274132 | 0.89 | NPC1 (0.61) | LMNAMAPTALDH1A1KMT2AHTT | |
| SCHEMBL30180739 | 0.89 | HTT (0.62) | LMNAMAPTALDH1A1KMT2AHTT | |
| Sulisobenzone SCHEMBL29378407 | 0.87 | LMNA (0.76) | LMNAMAPTALDH1A1KMT2AHTT | |
| Sulisobenzone SCHEMBL338882 | 0.87 | LMNA (0.76) | LMNAMAPTALDH1A1KMT2AHTT | |
| Lithium Ion SCHEMBL10491553 | 0.86 | NPC1 (0.61) | LMNAMAPTALDH1A1KMT2AHTT | |
| Potassium Ion SCHEMBL10491864 | 0.86 | NPC1 (0.61) | LMNAMAPTALDH1A1KMT2AHTT | |
| Sulisobenzone SCHEMBL11277588 | 0.84 | LMNA (0.76) | LMNAMAPTALDH1A1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 679 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3600224-B1 | SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2026-05-06 | — | — | EP | claimed |
| US-20250236727-A1 | THERMOPLASTIC RESIN COMPOSITION, METHOD OF PREPARING THE SAME, AND MOLDED ARTICLE INCLUDING THE SAME | LG CHEM, LTD. (KR) | 2025-07-24 | — | — | US | claimed |
| EP-4397709-A1 | THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED ARTICLE INCLUDING SAME | LG Chem, Ltd. (KR) | 2024-07-10 | — | — | EP | claimed |
| WO-2024085404-A1 | THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED ARTICLE INCLUDING SAME | (주) 엘지화학 | 2024-04-25 | — | — | WO | claimed |
| US-11865785-B2 | Continuous digital light processing additive manufacturing of implants | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2024-01-09 | — | — | US | claimed |
| US-20230212090-A1 | IMPROVEMENTS IN FOLIAR FERTILIZERS | EVERRIS INTERNATIONAL B.V. (NL) | 2023-07-06 | — | — | US | claimed |
| WO-2023086591-A1 | SUNSCREEN SOAP | DAUGHERTY HEIDI (US) | 2023-05-19 | — | — | WO | claimed |
| EP-3915375-A1 | IMPROVEMENTS IN FOLIAR FERTILIZERS | Everris International B.V. (NL) | 2021-12-01 | — | — | EP | claimed |
| WO-2021006411-A1 | BLUE LIGHT-BLOCKING CONTACT LENS AND MANUFACTURING METHOD THEREFOR | 주식회사 인터로조 | 2021-01-14 | — | — | WO | claimed |
| US-20190210355-A1 | ABSORBANT AND REFLECTING BIOCOMPATIBLE DYES FOR HIGHLY ACCURATE MEDICAL IMPLANTS | WILLIAM ,MARSH RICE UNIVERSITY | 2019-07-11 | — | — | US | claimed |
| US-20150314039-A1 | ABSORBANT AND REFLECTING BIOCOMPATIBLE DYES FOR HIGHLY ACCURATE MEDICAL IMPLANTS | WILLIAM ,MARSH RICE UNIVERSITY | 2015-11-05 | — | — | US | claimed |
| EP-2918260-A1 | UV screening emulsifiedcomposition comprising surface treated zinc oxide | KAO CORPORATION (JP) | 2015-09-16 | — | — | EP | claimed |
| US-8728503-B2 | Emulsion cosmetic | KAO CORPORATION (JP) | 2014-05-20 | — | — | US | claimed |
| EP-2497457-A1 | EMULSION COSMETIC | Kao Corporation (JP) | 2012-09-12 | — | — | EP | claimed |
| US-20120219608-A1 | EMULSION COSMETIC | KAO CORPORATION (JP) | 2012-08-30 | — | — | US | claimed |
| WO-2007110415-A2 | USE OF DIACETYL TRIMERS AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING THESE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2007-10-04 | — | — | WO | claimed |
| US-7186416-B2 | Foamable pharmaceutical compositions and methods for treating a disorder | STIEFEL LABORATORIES, INC. (US) | 2007-03-06 | — | — | US | claimed |
| US-6046330-A | Complexes of ultraviolet absorbers and quaternary ammonium compounds which are substantially free from unwanted salts | MILLIKEN & COMPANY | 2000-04-04 | — | — | US | claimed |
| EP-0193932-A2 | Sunscreen composition for hair protection | Revlon, Inc. (US) | 1986-09-10 | — | — | EP | claimed |
| US-4567038-A | MOUSSE BASE | REVLON, INC. (US) | 1986-01-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120219608-A1 | EMULSION COSMETIC | CUTA, LAGE3, SFN | HMGCR 2443/4885ADORA3 4386/4885LMNA 1995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.